Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
News News
Thursday, October 5, 2017
Promethera Biosciences and Shibuya Announce Strategic Collaboration to Establish Breakthrough Cell Therapy Manufacturing Platform
Monday, September 18, 2017
Ncardia established following Pluriomics Axiogenesis merger
Monday, August 21, 2017
Pluriomics BV announced cooperation with ACEA Biosciences Inc to advance cardiovascular drug discovery and the expansion of its services portfolio
Thursday, August 3, 2017
Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated fibroblasts
Thursday, July 27, 2017
Complix Announces Expanded Strategic Oncology Collaboration with MSD to Develop Cell-Penetrating Alphabodies
Wednesday, June 21, 2017
Pluriomics’ Pluricyte® Cardiomyocytes selected by Wageningen University as model system to elucidate poorly understood methadone toxicity mechanisms
Tuesday, May 30, 2017
Pluriomics BV partners with Pivot Park Screening Centre to offer ultra High Throughput Screening for Cardiovascular drug discovery services
Wednesday, May 24, 2017
Pluriomics BV collaborates with Multi Channel Systems to expand its Cardiovascular screening capabilities and its drug discovery services portfolio